Celgene enters Triphase with $40m

Feb 1, 2019 • Callum Cyrus

Facit-backed oncological development initiative Triphase Accelerator has struck a deal with Celgene for its TRPH-395 blood cancer treatment as the drug nears clinical trials

Triphase Accelerator, a Canada-based oncological treatment accelerator backed by commercialisation agency Fight Against Cancer Innovation Trust (Facit), is to receive $40m upfront under a business development pact with drug maker Celgene.
Facit provides funding to advance local oncological projects including spinouts and is allied to the Ontario Institute for Cancer Research.
Under the partnership, Triphase Accelerator will fund proof-of-concept clinical trials of its precision TRPH-395 therapy in blood cancer indications, which recognises specific DNA hallmarks of blood cancer…

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

Can University of Kentucky researchers bring new flavours to whisky?

The University of Kentucky has formed an industry-university partnership to advance aspects such as sustainable agriculture in the whiskey distilling industry.

UK universities ready to pick up the pace of commercialisation in 2025

The UK stands to benefit from the work of the past 12 months to push more university research-led innovation into the marketplace.

Databricks cofounder launches $150m spinout fund with UC Berkeley focus

The investment fund will mostly back founders from the US university.

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

May 1 -
May 6, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.